CMF
RMD icon

Counterpoint Mutual Funds’s ResMed RMD Stock Holding History

Counterpoint Mutual Funds’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,233
Closed -$297K – 462
2025
Q4 		$297K Buy
+1,233
New +$315K 0.02% 255
2023
Q4 		– Sell
-908
Closed -$134K – 256
2023
Q3 		$134K Buy
+908
New +$164K 0.11% 89

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Counterpoint Mutual Funds's RMD Position: Q1 2026 in Review

Counterpoint Mutual Funds sold out of ResMed (RMD) in Q1 2026, closing a stake of 1,233 shares — an estimated $297K sold.

Counterpoint Mutual Funds first reported a position in RMD in Q3 2023 and held it in 2 quarters. The position peaked at $297K in Q4 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Counterpoint Mutual Funds reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 1,233 ResMed shares in Q1 2026, an estimated $297K.
  • Counterpoint Mutual Funds first reported a position in ResMed in Q3 2023 and held it in 2 quarters.
  • Counterpoint Mutual Funds's ResMed position peaked at $297K in Q4 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2026, filed 27 Apr 2026.